Professor from INRS receives NIH grant to explore biomedical potential in field of oncology

NewsGuard 100/100 Score

Professor Nicolas Doucet of the Centre INRS-Institut Armand-Frappier has just received a research grant from the National Institutes of Health (NIH) in the amount of nearly US$600,000. The 5-year grant is to pursue cutting-edge research in the workings of tiny proteins called RNases and to explore their biomedical potential in the field of oncology as well as in inflammation and asthma.

"Receiving a grant at this level is an accomplishment in itself," said Yves B-gin, vice president of research and academic affairs at INRS. "It recognizes outstanding achievement. It is also a sign of the importance and potential of Professor Doucet's work on proteins in movement, further contributing to our understanding of how living beings work."

Professor Doucet will work with two American researchers to develop new computer and experimental tools for studying the dynamics of ribonucleases (RNases) and the processes involved in enzyme catalysis, molecular recognition, and signalling. Their approach is based on experimental computation and molecular dynamics and combines modelling, molecular simulation, and nuclear magnetic resonance (NMR).

Professor Doucet and his team are interested in this family of enzymes and its essential role in the formation of new blood vessels, the degradation of ribonucleic acid (RNA), and in defending against RNA viruses. A better understanding of their molecular function and dynamics could lead to new medications for inhibiting the proliferation of cancer cells or fighting a number of pathogens. The new methodologies they develop could also be used to study other enzyme systems.

Professor Doucet's NMR characterization of the ribonuclease superfamily project is part of the NIH-funded "Conformational sub-states in enzyme catalysis: Applications to the ribonuclease family" research initiative being conducted in partnership with the University of Pittsburgh's Professor Chakra Chennubhotla and Professor Pratul K. Agarwal of Oak Ridge National Laboratory in Tennessee.

Source:

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
UCLA study finds pre-surgery immunotherapy safe for pancreatic cancer patients